Karen L. Smith serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Karen L. Smith has executed 52 insider transactions totaling $3.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 6, 2026 involved receiving (via award) 35,000 shares valued at $0.
Karen L. Smith currently holds 35,000 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen L. Smith has been a net seller of JAZZ stock. They have purchased $250.0K and sold $2.9M worth of shares.
Karen L. Smith's most recent insider trade was on Feb 6, 2026, when they sold 35,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 1, 2023 | SGMO | $0 | Award | 13,900 | $N/A | Discretionary |
| May 24, 2022 | ATRS | $303.5K | Disposition | 54,193 | $5.60 | Discretionary |
| May 24, 2022 | ATRS | $142.5K | Disposition | 25,452 | $5.60 | Discretionary |
| May 19, 2022 | CRTX | $0 | Award | 24,336 | $N/A | Discretionary |
| May 19, 2022 | CRTX | $0 | Award | 170,354 | $N/A | Discretionary |
| Feb 25, 2022 | SGMO | $0 | Award | 12,500 | $N/A | Discretionary |
| Nov 19, 2021 | XLRN | $0 | Tender | 1,622 | $N/A | Discretionary |
| Jun 10, 2021 | ATRS | $112.5K | Award | 25,452 | $4.42 | Discretionary |
| May 7, 2021 | EBS | $18.6K | Payment | 305 | $60.85 | Discretionary |
| Apr 5, 2021 | XLRN | $90.5K | Sale | 641 | $141.15 | Discretionary |
| Apr 5, 2021 | XLRN | $176.7K | Option Exercise | 5,000 | $35.34 | Discretionary |
| Apr 5, 2021 | XLRN | $78.1K | Option Exercise | 1,875 | $41.64 | Discretionary |
| Apr 5, 2021 | XLRN | $1.6M | Sale | 11,223 | $140.13 | Discretionary |
| Apr 5, 2021 | XLRN | $108.6K | Option Exercise | 2,050 | $52.99 | Discretionary |
| Apr 1, 2021 | XLRN | $161.6K | Sale | 1,201 | $134.54 | Discretionary |
| Apr 1, 2021 | XLRN | $108.6K | Option Exercise | 2,050 | $52.99 | Discretionary |
| Apr 1, 2021 | XLRN | $78.1K | Option Exercise | 1,875 | $41.64 | Discretionary |
| Apr 1, 2021 | XLRN | $406.9K | Sale | 2,987 | $136.22 | Discretionary |
| Apr 1, 2021 | XLRN | $519.7K | Sale | 3,796 | $136.92 | Discretionary |
| Apr 1, 2021 | XLRN | $129.8K | Sale | 941 | $137.92 | Discretionary |
| Apr 1, 2021 | XLRN | $176.7K | Option Exercise | 5,000 | $35.34 | Discretionary |
| Feb 25, 2021 | SGMO | $0 | Award | 8,200 | $N/A | Discretionary |
| Feb 24, 2021 | EBS | $0 | Award | 2,942 | $N/A | Discretionary |
| Feb 24, 2021 | EBS | $0 | Award | 2,941 | $N/A | Discretionary |
| Jan 29, 2021 | XLRN | $0 | Award | 1,622 | $N/A | Discretionary |
| Jun 11, 2020 | ATRS | $82.5K | Award | 30,220 | $2.73 | Discretionary |
| May 18, 2020 | SGMO | $0 | Award | 2,500 | $N/A | Discretionary |
| May 18, 2020 | SGMO | $0 | Award | 10,000 | $N/A | Discretionary |